Literature DB >> 33506254

Quantifying the transmission advantage associated with N501Y substitution of SARS-CoV-2 in the UK: an early data-driven analysis.

Shi Zhao1,2, Jingzhi Lou1, Lirong Cao1, Hong Zheng1, Marc K C Chong1,2, Zigui Chen3, Renee W Y Chan4, Benny C Y Zee1,2, Paul K S Chan3, Maggie H Wang1,2.   

Abstract

Entities:  

Keywords:  B.1.1.7 lineage; COVID-19; mutation; reproduction number; statistical modelling; transmission advantage

Year:  2021        PMID： 33506254     DOI： 10.1093/jtm/taab011

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  29 in total

1.  Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China.

Authors:  Hengcong Liu; Juanjuan Zhang; Wenhong Zhang; Marco Ajelli; Hongjie Yu; Jun Cai; Xiaowei Deng; Cheng Peng; Xinghui Chen; Juan Yang; Qianhui Wu; Xinhua Chen; Zhiyuan Chen; Wen Zheng; Cécile Viboud
Journal:  BMC Med       Date:  2022-01-31       Impact factor: 8.775

Review 2.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

3.  Age-Dependent Risks of COVID-19 Putatively Caused by Variant Alpha in Japan.

Authors:  Taishi Kayano; Katsuma Hayashi; Tetsuro Kobayashi; Hiroshi Nishiura
Journal:  Front Public Health       Date:  2022-06-10

4.  The importance of the generation interval in investigating dynamics and control of new SARS-CoV-2 variants.

Authors:  Sang Woo Park; Benjamin M Bolker; Sebastian Funk; C Jessica E Metcalf; Joshua S Weitz; Bryan T Grenfell; Jonathan Dushoff
Journal:  J R Soc Interface       Date:  2022-06-15       Impact factor: 4.293

5.  A tentative assessment of the changes in transmissibility and fatality risk associated with Beta SARS-CoV-2 variants in South Africa: an ecological study.

Authors:  Shi Zhao; Zhihang Peng; Maggie H Wang
Journal:  Pathog Glob Health       Date:  2021-12-20       Impact factor: 3.735

Review 6.  Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines.

Authors:  Weilin Zhou; Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-06-09

7.  SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.

Authors:  Markus Hoffmann; Prerna Arora; Rüdiger Groß; Alina Seidel; Bojan F Hörnich; Alexander S Hahn; Nadine Krüger; Luise Graichen; Heike Hofmann-Winkler; Amy Kempf; Martin S Winkler; Sebastian Schulz; Hans-Martin Jäck; Bernd Jahrsdörfer; Hubert Schrezenmeier; Martin Müller; Alexander Kleger; Jan Münch; Stefan Pöhlmann
Journal:  Cell       Date:  2021-03-20       Impact factor: 41.582

8.  Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2.

Authors:  Shi Zhao; Jingzhi Lou; Marc K C Chong; Lirong Cao; Hong Zheng; Zigui Chen; Renee W Y Chan; Benny C Y Zee; Paul K S Chan; Maggie H Wang
Journal:  Viruses       Date:  2021-04-08       Impact factor: 5.048

9.  Estimating COVID-19 cases infected with the variant alpha (VOC 202012/01): an analysis of screening data in Tokyo, January-March 2021.

Authors:  Hiroaki Murayama; Taishi Kayano; Hiroshi Nishiura
Journal:  Theor Biol Med Model       Date:  2021-07-17       Impact factor: 2.432

10.  The challenge of screening SARS-CoV-2 variants of concern with RT-qPCR: One variant can hide another.

Authors:  Laurent Blairon; Roberto Cupaiolo; Sébastien Piteüs; Ingrid Beukinga; Marie Tré-Hardy
Journal:  J Virol Methods       Date:  2021-07-29       Impact factor: 2.014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.